15.96
price up icon1.98%   0.31
pre-market  시장 영업 전:  16.36   0.40   +2.51%
loading
전일 마감가:
$15.65
열려 있는:
$15.65
하루 거래량:
647.70K
Relative Volume:
0.75
시가총액:
$2.13B
수익:
-
순이익/손실:
$-151.09M
주가수익비율:
-10.23
EPS:
-1.56
순현금흐름:
$-160.51M
1주 성능:
+8.94%
1개월 성능:
+26.67%
6개월 성능:
+5.28%
1년 성능:
+67.65%
1일 변동 폭
Value
$15.26
$16.00
1주일 범위
Value
$14.17
$16.00
52주 변동 폭
Value
$9.00
$19.09

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile

Name
명칭
Centessa Pharmaceuticals Plc Adr
Name
전화
44 7391 789784
Name
주소
3RD FLOOR, ALTRINCHAM, CHESHIRE
Name
직원
86
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CNTA's Discussions on Twitter

CNTA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CNTA
Centessa Pharmaceuticals Plc Adr
15.96 1.96B 0 -151.09M -160.51M -1.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.27 123.14B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
550.00 60.43B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.69 42.07B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
572.71 34.47B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
290.35 27.42B 3.81B -644.79M -669.77M -6.24

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-28 개시 Needham Buy
2025-05-08 개시 Chardan Capital Markets Buy
2025-03-31 개시 Piper Sandler Overweight
2025-01-07 개시 TD Cowen Buy
2024-09-20 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-09-19 개시 B. Riley Securities Buy
2024-07-18 개시 Oppenheimer Outperform
2023-11-15 업그레이드 Jefferies Hold → Buy
2023-10-26 업그레이드 Morgan Stanley Underweight → Equal-Weight
2023-06-21 개시 Evercore ISI Outperform
2023-06-12 개시 Guggenheim Buy
2023-03-17 개시 SVB Securities Outperform
2022-08-12 다운그레이드 Morgan Stanley Overweight → Underweight
2022-06-17 개시 BMO Capital Markets Outperform
2022-06-03 다운그레이드 Jefferies Buy → Hold
2022-02-11 개시 Goldman Neutral
모두보기

Centessa Pharmaceuticals Plc Adr 주식(CNTA)의 최신 뉴스

pulisher
Jul 16, 2025

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Buy” by Analysts - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 16, 2025
pulisher
Jun 27, 2025

Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 3.8% After Insider Selling - Defense World

Jun 27, 2025
pulisher
Jun 17, 2025

Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Jun 17, 2025
pulisher
Jun 16, 2025

Centessa Gets US FDA's Clearance to Start Phase 1 Trial of ORX142 for Neurological, Neurodegenerative Disorders - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Centessa Pharmaceuticals plc Announces Clearance of Investigational New Drug Application for ORX142 - MarketScreener

Jun 16, 2025
pulisher
Jun 09, 2025

SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest - Quantisnow

Jun 09, 2025
pulisher
Jun 05, 2025

Wall Street Analysts Think Centessa Pharmaceuticals (CNTA) Could Surge 138.77%: Read This Before Placing a Bet - MSN

Jun 05, 2025
pulisher
May 29, 2025

Centessa Pharmaceuticals Announces Executive Changes By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Centessa Pharmaceuticals Announces Executive Changes - Investing.com India

May 29, 2025
pulisher
May 14, 2025

Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 License and Other Revenue of $15M - marketscreener.com

May 14, 2025
pulisher
May 10, 2025

Is Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) A Suitable Stock For New Investors Today? - Stocksregister

May 10, 2025
pulisher
May 07, 2025

Ratios in Focus: Analyzing Centessa Pharmaceuticals plc ADR (CNTA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 07, 2025
pulisher
May 02, 2025

Investor’s Delight: Centessa Pharmaceuticals plc ADR (CNTA) Closes Weak at 13.50, Down -1.53 - DWinneX

May 02, 2025
pulisher
May 01, 2025

Was Centessa Pharmaceuticals plc ADR (CNTA)’s session last reading good? - uspostnews.com

May 01, 2025
pulisher
Apr 24, 2025

Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

Investor’s Toolkit: Key Ratios for Assessing MSCI Inc (MSCI)’s Performance - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Metrics Check: Centessa Pharmaceuticals plc ADR (CNTA)’s Ratios for Trailing Twelve Months - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

Should investors be concerned about Centessa Pharmaceuticals plc ADR (CNTA)? - uspostnews.com

Apr 23, 2025
pulisher
Apr 10, 2025

Parsons Corp (PSN) Shares Up Despite Recent Market Volatility - News Heater

Apr 10, 2025
pulisher
Apr 01, 2025

Lantheus Holdings Inc [LNTH] Insider Activity: An Update for Investors - knoxdaily.com

Apr 01, 2025
pulisher
Mar 31, 2025

Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target - MarketScreener

Mar 31, 2025
pulisher
Mar 26, 2025

Centessa Pharmaceuticals chief business officer sells $163,386 in stock - Investing.com

Mar 26, 2025
pulisher
Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 - Investing.com India

Mar 21, 2025
pulisher
Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Centessa Pharmaceuticals’ general counsel sells $98,697 in stock - Investing.com

Mar 19, 2025
pulisher
Mar 03, 2025

Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register

Mar 03, 2025
pulisher
Feb 25, 2025

Ratios Revealed: Decoding Centessa Pharmaceuticals plc ADR (CNTA)’s Financial Health - The Dwinnex

Feb 25, 2025
pulisher
Feb 18, 2025

Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight - GlobeNewswire Inc.

Feb 18, 2025
pulisher
Feb 11, 2025

Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com India

Feb 11, 2025
pulisher
Feb 10, 2025

Aegon Ltd (AEG) looking to reclaim success with recent performance - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

Adversity is less terrifying than hope: Wayfair Inc (W) - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News

Feb 10, 2025
pulisher
Feb 10, 2025

Taking the lead: Centessa Pharmaceuticals plc ADR (CNTA) - SETE News

Feb 10, 2025
pulisher
Feb 07, 2025

Centessa Pharmaceuticals plc ADR (CNTA) Volatility Hits 6.67%: What Good Investors Need To Be Aware Of - Stocks Register

Feb 07, 2025
pulisher
Feb 07, 2025

RLI Corp’s (RLI) Stock: A Week-by-Week Analysis - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Centessa Pharmaceuticals plc ADR (CNTA) Shares Up Despite Recent Market Volatility - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Aon plc (AON) Stock: Evaluating the Market Performance - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Qudian Inc ADR (QD) Stock: A Look at the Analyst Recommendations - The News Heater

Feb 07, 2025
pulisher
Feb 07, 2025

Examining the Volatility of Costamare Inc’s (CMRE) Stock - The News Heater

Feb 07, 2025
pulisher
Feb 04, 2025

Centessa Pharmaceuticals officer Tia Bush sells $185,406 in shares - Investing.com

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Fitness Check: Examining Magna International Inc (MGA)’s Key Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Metrics Exploration: Understanding Oncolytics Biotech, Inc (ONCY) Through Ratios - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Financial Health Report: EyePoint Pharmaceuticals Inc (EYPT)’s Ratios Tell a Tale - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News

Feb 04, 2025
pulisher
Jan 29, 2025

Centessa Pharmaceuticals chief business officer sells shares worth $193,429 - Investing.com India

Jan 29, 2025
pulisher
Jan 22, 2025

Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com

Jan 22, 2025

Centessa Pharmaceuticals Plc Adr (CNTA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$22.01
price up icon 0.64%
$35.47
price down icon 0.37%
$104.17
price down icon 0.40%
$27.63
price down icon 2.26%
$111.04
price down icon 1.29%
biotechnology ONC
$290.35
price up icon 4.01%
자본화:     |  볼륨(24시간):